INVITROGEN BRINGS ANIMAL-ORIGIN FREE MEDIA FORMULATION TO NEW FACILITY

June 12, 2006

Biotechnology firm Invitrogen has opened a new facility in New York which can make its Advanced Granulation Technology (AGT) media totally free of animal origin components while addressing key bottlenecks in drug production.

DrugResearcher.com (http://www.drugresearcher.com/news/ng.asp?n=68335-invitrogen-agt-dry-powder-media)

KEYWORDS Daily International Pharma Alert

Luminex Receives EUA for Expanded Respiratory Pathogen Panel, Clearing It for COVID-19

INVITROGEN BRINGS ANIMAL-ORIGIN FREE MEDIA FORMULATION TO NEW FACILITY

Upcoming Events

FDA Drug GMP Facility Inspections During the Pandemic

Pharmaceutical Naming Regulation: Understanding the Latest Developments

Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19

Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges

Medical Device Cybersecurity: Understand the Latest Developments

Featured Products

Biological Risk Evaluation and Management for Medical Devices

GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

Abbott Gets FDA EUA for COVID-19 IgG Antibody Test

In $1.55 Billion Deal, Perrigo Sells Off Generic Drug Business

Turkish Researchers Downgrade Sinovac’s COVID-19 Vaccine Efficacy Rate

Luminex Receives EUA for Expanded Respiratory Pathogen Panel, Clearing It for COVID-19

The Revised ICH E8: A Guide to New Clinical Trial Requirements